Stock Quote
Cubist Pharmaceuticals, Inc. (CBST.O) (Nasdaq)
$16.97
3:01pm EST
+0.12%
$16.95
$17.07
247,126
$17.23
$16.95
$28.74
$13.81
0.63
726,320
CBST.O
More News
| Press Releases
| Key Developments
| Name | Current Position | Compensation |
|---|---|---|
| Bonney, Michael | President, Chief Executive Officer, Director | 1,905,064 |
| McGirr, David | Chief Financial Officer, Senior Vice President | 923,301 |
| Perez, Robert | Chief Operating Officer, Executive Vice President | 1,187,316 |
Profile
Cubist Pharmaceuticals, Inc. (Cubist), is a biopharmaceutical company focused on the research, development and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment. The Company's products are used primarily in hospitals but also may be used in... Full Description
Company Address
Cubist Pharmaceuticals, Inc.
65 Hayden Avenue
Lexington MA 02421
P: +1781.8608660
F: +1781.8610566
65 Hayden Avenue
Lexington MA 02421
P: +1781.8608660
F: +1781.8610566
Analyst Research
Performance of Key Competitors
| Company | Price | Change |
|---|---|---|
| Abbott Laboratories | $53.07 | -0.57 |
| Shionogi & Co., Ltd. | ¥1,838.00 | +10.00 |
| Pfizer Inc. | $18.59 | +0.23 |
| CBST.O | Industry | |
|---|---|---|
| P/E(TTM) | 6.13 | 12.80 |
| P/S(TTM) | 1.87 | 29.90 |
| ROI(TTM) | 30.71 | 2.35 |
| ROE(TTM) | 61.38 | 3.59 |
| Consensus Recommendation | Hold |
|---|---|
| EPS Est. (Current Period) | 0.29 |
| EPS Est. (Current Year) | 1.38 |
| Total Revenue | $143.53M |
| Net Income | $25.38M |
| EPS | $0.41 |
